Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Neurological Biomarkers Market 2017 Forecast to 2022

Table of Contents

1 Market Overview

• 1.1 Neurological Biomarkers Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Proteomics
  • 1.2.2 Genomics
  • 1.2.3 Imaging
  • 1.2.4 Bioinformatics
  • 1.2.5 Others
• 1.3 Market Analysis by Applications
  • 1.3.1 Diagnostics
  • 1.3.2 Drug Discovery
  • 1.3.3 Personalized Medicine
  • 1.3.4 Others
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (USA, Canada and Mexico)
    • 1.4.1.1 USA Market States and Outlook (2012-2022)
    • 1.4.1.2 Canada Market States and Outlook (2012-2022)
    • 1.4.1.3 Mexico Market States and Outlook (2012-2022)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2012-2022)
    • 1.4.2.2 France Market States and Outlook (2012-2022)
    • 1.4.2.3 UK Market States and Outlook (2012-2022)
    • 1.4.2.4 Russia Market States and Outlook (2012-2022)
    • 1.4.2.5 Italy Market States and Outlook (2012-2022)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2012-2022)
    • 1.4.3.2 Japan Market States and Outlook (2012-2022)
    • 1.4.3.3 Korea Market States and Outlook (2012-2022)
    • 1.4.3.4 India Market States and Outlook (2012-2022)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2012-2022)
    • 1.4.4.2 Egypt Market States and Outlook (2012-2022)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    • 1.4.4.4 South Africa Market States and Outlook (2012-2022)
    • 1.4.4.5 Nigeria Market States and Outlook (2012-2022)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Thermo Fisher
  • 2.1.1 Business Overview
    • 2.1.1.1 Thermo Fisher Neurological Biomarkers Description
    • 2.1.1.2 Thermo Fisher Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.1.2 Thermo Fisher Neurological Biomarkers Product Introduction
    • 2.1.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.1.2.2 Thermo Fisher Neurological Biomarkers Product Introduction
  • 2.1.3 Thermo Fisher Neurological Biomarkers Sales, Revenue and Market Share
    • 2.1.3.1 Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.1.3.2 Thermo Fisher Neurological Biomarkers Market Share in Global in 2016
• 2.2 Merck
  • 2.2.1 Business Overview
    • 2.2.1.1 Merck Neurological Biomarkers Description
    • 2.2.1.2 Merck Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.2.2 Thermo Fisher Neurological Biomarkers Product Introduction
    • 2.2.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.2.2.2 Merck Neurological Biomarkers Product Introduction
  • 2.2.3 Merck Neurological Biomarkers Sales, Revenue and Market Share
    • 2.2.3.1 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2.3.2 Merck Neurological Biomarkers Market Share in Global in 2016
• 2.3 Bio-Rad Laboratories
  • 2.3.1 Business Overview
    • 2.3.1.1 Bio-Rad Laboratories Neurological Biomarkers Description
    • 2.3.1.2 Bio-Rad Laboratories Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.3.2 Bio-Rad Laboratories Neurological Biomarkers Product Introduction
    • 2.3.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.3.2.2 Bio-Rad Laboratories Neurological Biomarkers Product Introduction
  • 2.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Market Share
    • 2.3.3.1 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3.3.2 Bio-Rad Laboratories Neurological Biomarkers Market Share in Global in 2016
• 2.4 Roche
  • 2.4.1 Business Overview
    • 2.4.1.1 Roche Neurological Biomarkers Description
    • 2.4.1.2 Roche Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.4.2 Roche Neurological Biomarkers Product Introduction
    • 2.4.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.4.2.2 Roche Neurological Biomarkers Product Introduction
  • 2.4.3 Roche Neurological Biomarkers Sales, Revenue and Market Share
    • 2.4.3.1 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4.3.2 Roche Neurological Biomarkers Market Share in Global in 2016
• 2.5 QIAGEN
  • 2.5.1 Business Overview
    • 2.5.1.1 QIAGEN Neurological Biomarkers Description
    • 2.5.1.2 QIAGEN Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.5.2 QIAGEN Neurological Biomarkers Product Introduction
    • 2.5.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.5.2.2 QIAGEN Neurological Biomarkers Product Introduction
  • 2.5.3 QIAGEN Neurological Biomarkers Sales, Revenue and Market Share
    • 2.5.3.1 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5.3.2 QIAGEN Neurological Biomarkers Market Share in Global in 2016
• 2.6 Athena Diagnostics
  • 2.6.1 Business Overview
    • 2.6.1.1 Athena Diagnostics Neurological Biomarkers Description
    • 2.6.1.2 Athena Diagnostics Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.6.2 Athena Diagnostics Neurological Biomarkers Product Introduction
    • 2.6.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.6.2.2 Athena Diagnostics Neurological Biomarkers Product Introduction
  • 2.6.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Market Share
    • 2.6.3.1 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6.3.2 Athena Diagnostics Neurological Biomarkers Market Share in Global in 2016
• 2.7 Myriad RBM
  • 2.7.1 Business Overview
    • 2.7.1.1 Myriad RBM Neurological Biomarkers Description
    • 2.7.1.2 Myriad RBM Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.7.2 Myriad RBM Neurological Biomarkers Product Introduction
    • 2.7.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.7.2.2 Myriad RBM Neurological Biomarkers Product Introduction
  • 2.7.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Market Share
    • 2.7.3.1 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7.3.2 Myriad RBM Neurological Biomarkers Market Share in Global in 2016
• 2.8 Cisbio Bioassays
  • 2.8.1 Business Overview
    • 2.8.1.1 Cisbio Bioassays Neurological Biomarkers Description
    • 2.8.1.2 Cisbio Bioassays Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.8.2 Cisbio Bioassays Neurological Biomarkers Product Introduction
    • 2.8.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.8.2.2 Cisbio Bioassays Neurological Biomarkers Product Introduction
  • 2.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Market Share
    • 2.8.3.1 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8.3.2 Cisbio Bioassays Neurological Biomarkers Market Share in Global in 2016
• 2.9 Wuxi APP
  • 2.9.1 Business Overview
    • 2.9.1.1 Wuxi APP Neurological Biomarkers Description
    • 2.9.1.2 Wuxi APP Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.9.2 Wuxi APP Neurological Biomarkers Product Introduction
    • 2.9.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.9.2.2 Wuxi APP Neurological Biomarkers Product Introduction
  • 2.9.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Market Share
    • 2.9.3.1 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9.3.2 Wuxi APP Neurological Biomarkers Market Share in Global in 2016
• 2.10 BGI
  • 2.10.1 Business Overview
    • 2.10.1.1 BGI Neurological Biomarkers Description
    • 2.10.1.2 BGI Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.10.2 BGI Neurological Biomarkers Product Introduction
    • 2.10.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.10.2.2 BGI Neurological Biomarkers Product Introduction
  • 2.10.3 BGI Neurological Biomarkers Sales, Revenue and Market Share
    • 2.10.3.1 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10.3.2 BGI Neurological Biomarkers Market Share in Global in 2016
• 2.11 Aepodia
  • 2.11.1 Business Overview
    • 2.11.1.1 Aepodia Neurological Biomarkers Description
    • 2.11.1.2 Aepodia Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.11.2 Aepodia Neurological Biomarkers Product Introduction
    • 2.11.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.11.2.2 Aepodia Neurological Biomarkers Product Introduction
  • 2.11.3 Aepodia Neurological Biomarkers Sales, Revenue and Market Share
    • 2.11.3.1 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.11.3.2 Aepodia Neurological Biomarkers Market Share in Global in 2016
• 2.12 Genewiz
  • 2.12.1 Business Overview
    • 2.12.1.1 Genewiz Neurological Biomarkers Description
    • 2.12.1.2 Genewiz Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.12.2 Genewiz Neurological Biomarkers Product Introduction
    • 2.12.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.12.2.2 Genewiz Neurological Biomarkers Product Introduction
  • 2.12.3 Genewiz Neurological Biomarkers Sales, Revenue and Market Share
    • 2.12.3.1 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.12.3.2 Genewiz Neurological Biomarkers Market Share in Global in 2016
• 2.13 Proteome Sciences
  • 2.13.1 Business Overview
    • 2.13.1.1 Proteome Sciences Neurological Biomarkers Description
    • 2.13.1.2 Proteome Sciences Neurological Biomarkers Headquarter, Main Business and Finance Overview
  • 2.13.2 Proteome Sciences Neurological Biomarkers Product Introduction
    • 2.13.2.1 Production Bases, Sales Regions and Major Competitors
    • 2.13.2.2 Proteome Sciences Neurological Biomarkers Product Introduction
  • 2.13.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Market Share
    • 2.13.3.1 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.13.3.2 Proteome Sciences Neurological Biomarkers Market Share in Global in 2016

  3 Global Neurological Biomarkers Market Competition, by Manufacturer

  • 3.1 Global Neurological Biomarkers Sales and Market Share by Manufacturer (2016-2017)
  • 3.2 Global Neurological Biomarkers Revenue and Market Share by Manufacturer (2016-2017)
  • 3.3 Global Neurological Biomarkers Price by Manufacturer (2016-2017)
  • 3.4 Market Concentration Rate
    • 3.4.1 Top 3 Neurological Biomarkers Manufacturer Market Share
    • 3.4.2 Top 5 Neurological Biomarkers Manufacturer Market Share
  • 3.5 Market Competition Trend

  4 Global Neurological Biomarkers Market Analysis by Regions

  • 4.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Neurological Biomarkers Sales by Regions (2012-2017)
    • 4.1.2 Global Neurological Biomarkers Revenue by Regions (2012-2017)
  • 4.2 North America Neurological Biomarkers Sales and Growth (2012-2017)
  • 4.3 Europe Neurological Biomarkers Sales and Growth (2012-2017)
  • 4.4 Asia-Pacific Neurological Biomarkers Sales and Growth (2012-2017)
  • 4.5 South America Neurological Biomarkers Sales and Growth (2012-2017)
  • 4.6 Middle East and Africa Neurological Biomarkers Sales and Growth (2012-2017)

  5 North America Neurological Biomarkers by Countries, Type, Application and Manufacturers

  • 5.1 North America Neurological Biomarkers Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Neurological Biomarkers Sales by Countries (2012-2017)
    • 5.1.2 North America Neurological Biomarkers Revenue by Countries (2012-2017)
    • 5.1.3 USA Neurological Biomarkers Sales and Growth (2012-2017)
    • 5.1.4 Canada Neurological Biomarkers Sales and Growth (2012-2017)
    • 5.1.5 Mexico Neurological Biomarkers Sales and Growth (2012-2017)
  • 5.2 North America Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
    • 5.2.1 North America Neurological Biomarkers Sales by Manufacturers (2016-2017)
    • 5.2.2 North America Neurological Biomarkers Revenue by Manufacturers (2016-2017)
  • 5.3 North America Neurological Biomarkers Sales by Type (2012-2017)
  • 5.4 North America Neurological Biomarkers Sales by Application (2012-2017)

  6 Europe Neurological Biomarkers by Countries, Type, Application and Manufacturers

  • 6.1 Europe Neurological Biomarkers Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Neurological Biomarkers Sales by Countries (2012-2017)
    • 6.1.2 Europe Neurological Biomarkers Revenue by Countries (2012-2017)
    • 6.1.3 Germany Neurological Biomarkers Sales and Growth (2012-2017)
    • 6.1.4 UK Neurological Biomarkers Sales and Growth (2012-2017)
    • 6.1.5 France Neurological Biomarkers Sales and Growth (2012-2017)
    • 6.1.6 Russia Neurological Biomarkers Sales and Growth (2012-2017)
    • 6.1.7 Italy Neurological Biomarkers Sales and Growth (2012-2017)
  • 6.2 Europe Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
    • 6.2.1 Europe Neurological Biomarkers Sales by Manufacturers (2016-2017)
    • 6.2.2 Europe Neurological Biomarkers Revenue by Manufacturers (2016-2017)
  • 6.3 Europe Neurological Biomarkers Sales by Type (2012-2017)
  • 6.4 Europe Neurological Biomarkers Sales by Application (2012-2017)

  7 Asia-Pacific Neurological Biomarkers by Countries, Type, Application and Manufacturers

  • 7.1 Asia-Pacific Neurological Biomarkers Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Neurological Biomarkers Sales by Countries (2012-2017)
    • 7.1.2 Asia-Pacific Neurological Biomarkers Revenue by Countries (2012-2017)
    • 7.1.3 China Neurological Biomarkers Sales and Growth (2012-2017)
    • 7.1.4 Japan Neurological Biomarkers Sales and Growth (2012-2017)
    • 7.1.5 Korea Neurological Biomarkers Sales and Growth (2012-2017)
    • 7.1.6 India Neurological Biomarkers Sales and Growth (2012-2017)
    • 7.1.7 Southeast Asia Neurological Biomarkers Sales and Growth (2012-2017)
  • 7.2 Asia-Pacific Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
    • 7.2.1 Asia-Pacific Neurological Biomarkers Sales by Manufacturers (2016-2017)
    • 7.2.2 Asia-Pacific Neurological Biomarkers Revenue by Manufacturers (2016-2017)
  • 7.3 Asia-Pacific Neurological Biomarkers Sales by Type (2012-2017)
  • 7.4 Asia-Pacific Neurological Biomarkers Sales by Application (2012-2017)

  8 South America Neurological Biomarkers by Countries, Type, Application and Manufacturers

  • 8.1 South America Neurological Biomarkers Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Neurological Biomarkers Sales by Countries (2012-2017)
    • 8.1.2 South America Neurological Biomarkers Revenue by Countries (2012-2017)
    • 8.1.3 Brazil Neurological Biomarkers Sales and Growth (2012-2017)
    • 8.1.4 Argentina Neurological Biomarkers Sales and Growth (2012-2017)
    • 8.1.5 Columbia Neurological Biomarkers Sales and Growth (2012-2017)
  • 8.2 South America Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
    • 8.2.1 South America Neurological Biomarkers Sales by Manufacturers (2016-2017)
    • 8.2.2 South America Neurological Biomarkers Revenue by Manufacturers (2016-2017)
  • 8.3 South America Neurological Biomarkers Sales by Type (2012-2017)
  • 8.4 South America Neurological Biomarkers Sales by Application (2012-2017)

  9 Middle East and Africa Neurological Biomarkers by Countries, Type, Application and Manufacturers

  • 9.1 Middle East and Africa Neurological Biomarkers Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Neurological Biomarkers Sales by Countries (2012-2017)
    • 9.1.2 Middle East and Africa Neurological Biomarkers Revenue by Countries (2012-2017)
    • 9.1.3 Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2017)
    • 9.1.4 UAE Neurological Biomarkers Sales and Growth (2012-2017)
    • 9.1.5 Egypt Neurological Biomarkers Sales and Growth (2012-2017)
    • 9.1.6 Nigeria Neurological Biomarkers Sales and Growth (2012-2017)
    • 9.1.7 South Africa Neurological Biomarkers Sales and Growth (2012-2017)
  • 9.2 Middle East and Africa Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
    • 9.2.1 Middle East and Africa Neurological Biomarkers Sales by Manufacturers (2016-2017)
    • 9.2.2 Middle East and Africa Neurological Biomarkers Revenue by Manufacturers (2016-2017)
  • 9.3 Middle East and Africa Neurological Biomarkers Sales by Type (2012-2017)
  • 9.4 Middle East and Africa Neurological Biomarkers Sales by Application (2012-2017)

  10 Global Neurological Biomarkers Market Segment by Type

  • 10.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Type (2012-2017)
    • 10.1.1 Global Neurological Biomarkers Sales and Market Share by Type (2012-2017)
    • 10.1.2 Global Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
  • 10.2 Proteomics Sales Growth and Price
    • 10.2.1 Global Proteomics Sales Growth (2012-2017)
    • 10.2.2 Global Proteomics Price (2012-2017)
  • 10.3 Genomics Sales Growth and Price
    • 10.3.1 Global Genomics Sales Growth (2012-2017)
    • 10.3.2 Global Genomics Price (2012-2017)
  • 10.4 Imaging Sales Growth and Price
    • 10.4.1 Global Imaging Sales Growth (2012-2017)
    • 10.4.2 Global Imaging Price (2012-2017)
  • 10.5 Bioinformatics Sales Growth and Price
    • 10.5.1 Global Bioinformatics Sales Growth (2012-2017)
    • 10.5.2 Global Bioinformatics Price (2012-2017)
  • 10.6 Others Sales Growth and Price
    • 10.6.1 Global Others Sales Growth (2012-2017)
    • 10.6.2 Global Others Price (2012-2017)

  11 Global Neurological Biomarkers Market Segment by Application

  • 11.1 Global Neurological Biomarkers Sales Market Share by Application (2012-2017)
  • 11.2 Diagnostics Sales Growth (2012-2017)
  • 11.3 Drug Discovery Sales Growth (2012-2017)
  • 11.4 Personalized Medicine Sales Growth (2012-2017)
  • 11.5 Others Sales Growth (2012-2017)

  12 Neurological Biomarkers Market Forecast (2017-2022)

  • 12.1 Global Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022)
  • 12.2 Neurological Biomarkers Market Forecast by Regions (2017-2022)
    • 12.2.1 North America Neurological Biomarkers Market Forecast (2017-2022)
    • 12.2.2 Europe Neurological Biomarkers Market Forecast (2017-2022)
    • 12.2.3 Asia-Pacific Neurological Biomarkers Market Forecast (2017-2022)
    • 12.2.4 South America Neurological Biomarkers Market Forecast (2017-2022)
    • 12.2.5 Middle East and Africa Neurological Biomarkers Market Forecast (2017-2022)
  • 12.3 Neurological Biomarkers Market Forecast by Type (2017-2022)
  • 12.4 Neurological Biomarkers Market Forecast by Application (2017-2022)

  13 Sales Channel, Distributors, Traders and Dealers

  • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
    • 13.1.2 Indirect Marketing
    • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers

  14 Research Findings and Conclusion

  15 Appendix

  • 15.1 Methodology
  • 15.2 Analyst Introduction